Related Experiment Video
Updated: Mar 8, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Performance comparison of NextSeq and Ion Proton platforms for molecular diagnosis of clinical oncology
Fei Cao1, Lianju Gao2, Longgang Wei2
1Department of Gastrointestinal Medical Oncology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin - China.
Purpose:
Next-generation sequencing is a powerful approach to detect genetic mutations with which cancer diagnosis and treatment can be tailored to the individual patient in the era of personalized and precision medicine. Ion Torrent Systems Ion Proton and Illumina NextSeq are 2 major targeted sequencing platforms; however, not much work has been done to compare these platforms' performance for mutation detection in formalin-fixed paraffin-embedded (FFPE) materials.
Methods:
We benchmarked the performance by using a collection of FFPE samples from 23 patients with different cancers for NextSeq and Ion Proton platforms. We report analysis of sequencing in terms of average coverage depth, read length, and variant detection.
Results:
Sequencing results by NextSeq and Ion Proton displayed near perfect coverage behavior (>99%) on target region. We analyzed the ability to call variants from each platform and found that Ion Proton sequencing can identify 89% of single nucleotide variants (SNVs) whose mutant allele frequency (MAF) is greater than or equal to 5% detected by the NextSeq pipeline in common analytical regions. The correlation coefficient of MAF for those common SNVs was 1.0046 (R2 = 0.973) between the 2 platforms. To call lower mutant frequency (5%-10%) mutations for NextSeq sequencing, coverage depth should be improved. The concordance of small insertions and deletions between these 2 pipelines was up to 100%.
Conclusions:
The 2 sequencing pipelines evaluated were able to generate usable sequence and had high concordance. They are proper for mutation detection in clinical application.
Insights
Illumina NextSeq and Ion Proton platforms show high concordance for detecting cancer mutations in FFPE tissues. Both are suitable for clinical mutation detection, with Ion Proton identifying 89% of SNVs above 5% MAF found by NextSeq.
Area of Science:
- Genomics and Bioinformatics
- Cancer Research
- Molecular Diagnostics
Background:
- Personalized and precision medicine rely on accurate genetic mutation detection for tailored cancer treatment.
- Formalin-fixed paraffin-embedded (FFPE) tissues are crucial for retrospective studies and clinical diagnostics.
- Limited comparative data exists for major next-generation sequencing (NGS) platforms like Illumina NextSeq and Ion Torrent Ion Proton using FFPE samples.
Purpose of the Study:
- To benchmark and compare the performance of Illumina NextSeq and Ion Torrent Ion Proton platforms for mutation detection in FFPE samples.
- To evaluate sequencing metrics including coverage depth, read length, and variant detection accuracy between the two platforms.
Main Methods:
- Benchmarking NGS platform performance using FFPE samples from 23 cancer patients.
- Analyzing sequencing data for average coverage depth, read length, and variant detection.
- Comparing variant calls, specifically single nucleotide variants (SNVs) and small insertions/deletions (indels).
Main Results:
- Both NextSeq and Ion Proton demonstrated high coverage (>99%) on target regions.
- Ion Proton identified 89% of SNVs (>=5% MAF) detected by NextSeq in common regions, with high MAF correlation (R2=0.973).
- Concordance for small insertions and deletions reached 100% between the platforms; improved coverage depth is recommended for NextSeq to detect lower MAF mutations (5%-10%).
Conclusions:
- Both evaluated NGS pipelines generate usable sequence data with high concordance.
- The Illumina NextSeq and Ion Torrent Ion Proton platforms are suitable for clinical mutation detection in FFPE samples.
- Comparative analysis provides valuable insights for selecting NGS platforms in precision oncology.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...